cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Repare Therapeutics Inc
9 own
11 watching
Current Price
$10.3
$0.11
(1.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
432.97M
52-Week High
52-Week High
18.68
52-Week Low
52-Week Low
8.31
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization432.97M
icon52-Week High18.68
icon52-Week Low8.31
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Repare Therapeutics Inc do?
N/A
Read More
How much money does Repare Therapeutics Inc make?
News & Events about Repare Therapeutics Inc.
Business Wire
1month ago
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today presented initial data from its ongoing Phase 1/2 TRESR clinical trial evaluating camonsertib (RP-3500/RG6526, partnered with Roche), a potent and selective oral small...
Globe Newswire
3 months ago
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX PR Newswire NEW YORK, Feb. 13, 2023 NEW YORK, Feb. 13, 2023...
Business Wire
3 months ago
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Investors who purchased Repare securities are encouraged to obtain additional information and assist the...
Zolmax
3 months ago
Morgan Stanley cut shares of Repare Therapeutics (NASDAQ:RPTX Get Rating) from an overweight rating to an equal weight rating in a report released on Friday, MarketBeat reports. The firm currently has $15.00 price objective on the stock, down from their previous price objective of $28.00. A number ...
Frequently Asked Questions
Frequently Asked Questions
What is Repare Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Repare Therapeutics Inc shares?
plus_minus_icon
How can I buy Repare Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Repare Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Repare Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Repare Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Repare Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Repare Therapeutics Inc?
plus_minus_icon
What percentage is Repare Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Repare Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.3
$0.11
(1.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00